BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

BillionToOne , Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new addition to UNITY Screen. For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT looks for the presence of the genetic variants that code for the corresponding fetal antigens. UNITY fetal antigen NIPT is available at 10+ weeks gestation, and may streamline management for most pregnancies thought to be at risk for Hemolytic Disease of the Fetus and Newborn (HDFN), a rare but potentially deadly condition.